An Act to renumber and amend 450.13 (1); to amend 102.425 (1) (c), 450.11 (4g) (title), 450.11 (4g) (a) 2., 450.13 (2), 450.13 (3) and 450.13 (5) (intro.); and to create 450.01 (1z), 450.11 (4g) (c), 450.11 (4i), 450.12 (4), 450.122, 450.13 (6) and 450.135 of the statutes; Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| Date / House | Action | Journal |
|---|---|---|
| 11/29/2017 Asm. | Introduced by Representatives Rohrkaste, Spiros, Kolste, Anderson, Berceau, R. Brooks, Considine, Crowley, Felzkowski, Fields, Horlacher, Jacque, Kooyenga, Kremer, Krug, Kuglitsch, Ohnstad, Sargent, Sinicki, Skowronski, Spreitzer, Thiesfeldt, Tusler, Subeck and Edming; cosponsored by Senators Vukmir, Carpenter, Craig, Olsen, Vinehout, Bewley and Marklein | |
| 11/29/2017 Asm. | Read first time and referred to Committee on Health | |
| 12/7/2017 Asm. | Representative Bernier added as a coauthor | |
| 12/13/2017 Asm. | Public hearing held | |
| 2/1/2018 Asm. | Executive action taken | |
| 2/20/2018 Asm. | Representatives Barca and Shankland added as coauthors | |
| 3/22/2018 Asm. | Report passage recommended by Committee on Health, Ayes 11, Noes 0 | |
| 3/22/2018 Asm. | Referred to committee on Rules | |
| 3/28/2018 Asm. | Failed to pass pursuant to Senate Joint Resolution 1 |
